DOCSLIB.ORG

Dietary Supplements

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dietary Supplements nutrients Dietary Supplements Edited by Johanna T. Dwyer and Paul M. Coates Printed Edition of the Special Issue Published in Nutrients www.mdpi.com/journal/nutrients Dietary Supplements Special Issue Editors Johanna T. Dwyer Paul M. Coates MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editors Johanna T. Dwyer Office of Dietary Supplements, National Institutes of Health USA Paul M. Coates Office of Dietary Supplements, National Institutes of Health USA Editorial Office MDPI St. Alban-Anlage 66 Basel, Switzerland This edition is a reprint of the Special Issue published online in the open access journal Nutrients (ISSN 2072-6643) from 2017–2018 (available at: http://www.mdpi.com/journal/nutrients/special_issues/dietary_supplements). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: Lastname, F.M.; Lastname, F.M. Article title. Journal Name Year, Article number, page range. First Edition 2018 ISBN 978-3-03842-921-0 (Pbk) ISBN 978-3-03842-922-7 (PDF) Articles in this volume are Open Access and distributed under the Creative Commons Attribution license (CC BY), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is © 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Table of Contents About the Special Issue Editors ..................................... vii Preface to ”Dietary Supplements” .................................... ix Johanna T. Dwyer, Paul M. Coates and Michael J. Smith Dietary Supplements: Regulatory Challenges and Research Resources doi: 10.3390/nu10010041 ........................................ 1 Jos´e Miguel Mart´ınez-Sanz, Isabel Sospedra, Eduard Balad´ıa, Laura Arranz, Roc´ıo Ortiz-Moncada and Angel Gil-Izquierdo Current Status of Legislation on Dietary Products for Sportspeople in a European Framework doi: 10.3390/nu9111225 ........................................ 25 Jos´e Miguel Mart´ınez-Sanz, Isabel Sospedra, Christian Manas ˜ Ortiz, Eduard Balad´ıa, Angel Gil-Izquierdo and Rocio Ortiz-Moncada Intended or Unintended Doping? A Review of the Presence of Doping Substances in Dietary Supplements Used in Sports doi: 10.3390/nu9101093 ........................................ 41 Ethan M. Balk and Alice H. Lichtenstein Omega-3 Fatty Acids and Cardiovascular Disease: Summary of the 2016 Agency of Healthcare Research and Quality Evidence Review doi: 10.3390/nu9080865 ........................................ 63 Angela M. Devlin, Cecil M. Y. Chau, Roger Dyer, Julie Matheson, Deanna McCarthy, Karin Yurko-Mauro, Sheila M. Innis and Ruth E. Grunau Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial doi: 10.3390/nu9090975 ........................................ 76 Carmen Lambert, Judit Cubedo, Teresa Padr´o, Joan S´anchez-Hern´andez, Rosa M. Antonijoan, Antonio Perez and Lina Badimon Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study doi: 10.3390/nu9060599 ........................................ 93 Floyd H. Chilton, Rahul Dutta, Lindsay M. Reynolds, Susan Sergeant, Rasika A. Mathias and Michael C. Seeds Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases doi: 10.3390/nu9111165 ........................................109 Sujatha Rajaram, Ellen Lan Yip, Rajneesh Reghunathan, Subburaman Mohan and Joan Sabat´e Effect of Altering Dietary n-6:n-3 Polyunsaturated Fatty Acid Ratio with Plant and Marine-Based Supplement on Biomarkers of Bone Turnover in Healthy Adults doi: 10.3390/nu9101162 ........................................135 Cecilia Tullberg, Gerd Vegarud, Ingrid Undeland and Nathalie Scheers Effects of Marine Oils, Digested with Human Fluids, on Cellular Viability and Stress Protein Expression in Human Intestinal Caco-2 Cells doi: 10.3390/nu9111213 ........................................144 iii Luiza Halmenschlager, Alexandre Machado Lehnen, Aline Marcadenti and Melissa Medeiros Markoski Omega-3 Fatty Acids Supplementation Differentially Modulates the SDF-1/CXCR-4 Cell Homing Axis in Hypertensive and Normotensive Rats doi: 10.3390/nu9080826 ........................................157 Christine L. Taylor, Christopher T. Sempos, Cindy D. Davis and Patsy M. Brannon Vitamin D: Moving Forward to Address Emerging Science doi: 10.3390/nu9121308 ........................................169 Clare F. Dix, Judith D. Bauer, Ian Martin, Sharon Rochester, Briony Duarte Romero, Johannes B. Prins and Olivia R. L. Wright Association of Sun Exposure, Skin Colour and Body Mass Index with Vitamin D Status in Individuals Who Are Morbidly Obese doi: 10.3390/nu9101094 ........................................184 Paulette D. Chandler, Deirdre K. Tobias, Lu Wang, Stephanie A. Smith-Warner, Daniel I. Chasman, Lynda Rose, Edward L. Giovannucci, Julie E. Buring, Paul M. Ridker, Nancy R. Cook, JoAnn E. Manson and Howard D. Sesso Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women doi: 10.3390/nu10010055 ........................................199 Patsy M. Brannon and Christine L. Taylor Iron Supplementation during Pregnancy and Infancy: Uncertainties and Implications for Research and Policy doi: 10.3390/nu9121327 ........................................210 Yanan Li, Han Jiang and Guangrong Huang Protein Hydrolysates as Promoters of Non-Haem Iron Absorption doi: 10.3390/nu9060609 ........................................227 Roberto Aquilani, Ginetto Carlo Zuccarelli, Anna Maria Condino, Michele Catani, Carla Rutili, Consiglia Del Vecchio, Pietro Pisano, Manuela Verri, Paolo Iadarola, Simona Viglio and Federica Boschi Despite Inflammation, Supplemented Essential Amino Acids May Improve Circulating Levels of Albumin and Haemoglobin in Patients after Hip Fractures doi: 10.3390/nu9060637 ........................................245 Francesca Uberti, Vera Morsanuto, Sabrina Ghirlanda and Claudio Molinari Iron Absorption from Three Commercially Available Supplements in Gastrointestinal Cell Lines doi: 10.3390/nu9091008 ........................................265 Abby G. Ershow, Sheila A. Skeaff, Joyce M. Merkel and Pamela R. Pehrsson Development of Databases on Iodine in Foods and Dietary Supplements doi: 10.3390/nu10010100 ........................................283 Wolfgang Marx, Laisa Teleni, Rachelle S. Opie, Jaimon Kelly, Skye Marshall, Catherine Itsiopoulos and Elizabeth Isenring Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis doi: 10.3390/nu9111224 ........................................303 iv Jean Nyakayiru, Kristin L. Jonvik, Jorn Trommelen, Philippe J. M. Pinckaers, Joan M. Senden, Luc J. C. van Loon and Lex B. Verdijk Beetroot Juice Supplementation Improves High-Intensity Intermittent Type Exercise Performance in Trained Soccer Players doi: 10.3390/nu9030314 ........................................327 Ewa Sadowska-Krepa, Barbara Kłapcinska, ´ Ilona Pokora, Przemysław Domaszewski, Katarzyna Kempa and Tomasz Podg´orski Effects of Six-Week Ginkgo biloba Supplementation on Aerobic Performance, Blood Pro/Antioxidant Balance, and Serum Brain-Derived Neurotrophic Factor in Physically Active Men doi: 10.3390/nu9080803 ........................................337 Chia-Chi Wang, Shu-Cheng Lin, Shu-Ching Hsu, Ming-Ta Yang and Kuei-Hui Chan Effects of Creatine Supplementation on Muscle Strength and Optimal Individual Post- Activation Potentiation Time of the Upper Body in Canoeists doi: 10.3390/nu9111169 ........................................348 David Phelan, Alfonso Prado-Cabrero and John M. Nolan Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations doi: 10.3390/nu9101133 ........................................358 P. Blaise Collins, Conrad P. Earnest, Ryan L. Dalton, Ryan J. Sowinski, Tyler J. Grubic, Christopher J. Favot, Adriana M. Coletta, Christopher Rasmussen, Mike Greenwood and Richard B. Kreider Short-Term Effects of a Ready-to-Drink Pre-Workout Beverage on Exercise Performance and Recovery doi: 10.3390/nu9080823 ........................................368 Takashi Uebanso, Saki Kano, Ayumi Yoshimoto, Chisato Naito, Takaaki Shimohata, Kazuaki Mawatari and Akira Takahashi Effects of Consuming Xylitol on Gut Microbiota and Lipid Metabolism in Mice doi: 10.3390/nu9070756 ........................................387 Elle McKenna, Alexis Hure, Anthony Perkins and Ellie Gresham Dietary Supplement Use during Preconception: The Australian Longitudinal Study on Women’s Health doi: 10.3390/nu9101119 ........................................399 Stacey K. O’Brien, Eva Malacova, Jill L. Sherriff and Lucinda J. Black The Prevalence and Predictors of Dietary Supplement Use in the Australian Population doi: 10.3390/nu9101154 ........................................411 Alissa J. Burnett, Katherine M. Livingstone, Julie L. Woods and Sarah A. McNaughton Dietary Supplement Use among Australian Adults: Findings from the 2011–2012 National Nutrition and Physical Activity Survey doi:
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 9.468,645 B2 Owoc (45) Date of Patent: Oct
    USOO9468645B2 (12) United States Patent (10) Patent No.: US 9.468,645 B2 OWOc (45) Date of Patent: Oct. 18, 2016 (54) HIGHLY SOLUBLE PURINE BOACTIVE (2013.01); A61K 9/0019 (2013.01); A61 K COMPOUNDS AND COMPOSITIONS 9/0095 (2013.01); A61K 9/4858 (2013.01); THEREOF A61 K3I/00 (2013.01); A61K 45/06 (2013.01); A23 V 2002/00 (2013.01) (71) Applicant: JHO Intellectual Property Holdings, (58) Field of Classification Search LLC, Davie, FL (US) CPC ..................... A23V 2002/00; A23V 2200/31; (72) Inventor: Jack Owoc, Weston, FL (US) A23V 2250/062: A23V 2250/21: A23V 2250/5108: A23V 2250/5118: A23V (*) Notice: Subject to any disclaimer, the term of this 2250/54246; A23V 2250/54252: A23V patent is extended or adjusted under 35 2250/704; A23V 2250/712: A61K 31/522; U.S.C. 154(b) by 3 days. A61K 2300/00; A61K 45/06; A61 K9/00 See application file for complete search history. (21) Appl. No.: 14/628,626 (56) References Cited (22) Filed: Feb. 23, 2015 U.S. PATENT DOCUMENTS (65) Prior Publication Data 837,282 A * 12/1906 Owoc ....................... EO1B 9/60 US 2015/O238494 A1 Aug. 27, 2015 238,292 5,973,005 A * 10/1999 D'Amelio, Sr. ... CO7C 277/08 514,565 Related U.S. Application Data 2006/0236421 A1* 10, 2006 Pennell ................ C12N 9/1007 800,278 (60) Provisional application No. 61/944,528, filed on Feb. 2009,0257997 A1* 10, 2009 Owoc .................. A61K9/0014 25, 2014. 424/94.1 (51) Int. C. * cited by examiner A6 IK3I/522 (2006.01) A6 IK 45/06 (2006.01) Primary Examiner – Debbie K Ware A2.3L 2/52 (2006.01) (74) Attorney, Agent, or Firm — David W.
    [Show full text]
  • Identification and Characterization of N 9-Methyltransferase Involved In
    ARTICLE https://doi.org/10.1038/s41467-020-15324-7 OPEN Identification and characterization of N9- methyltransferase involved in converting caffeine into non-stimulatory theacrine in tea Yue-Hong Zhang1,2,3,6, Yi-Fang Li1,2,3,6, Yongjin Wang1,3,6, Li Tan1,3, Zhi-Qin Cao1,2,3, Chao Xie1,2,3, Guo Xie4, Hai-Biao Gong1,2,3, Wan-Yang Sun1,2,3, Shu-Hua Ouyang1,2,3, Wen-Jun Duan1,2,3, Xiaoyun Lu1,3, Ke Ding 1,3, ✉ ✉ ✉ ✉ Hiroshi Kurihara1,2,3, Dan Hu 1,2,3 , Zhi-Min Zhang 1,3 , Ikuro Abe 5 & Rong-Rong He 1,2,3 1234567890():,; Caffeine is a major component of xanthine alkaloids and commonly consumed in many popular beverages. Due to its occasional side effects, reduction of caffeine in a natural way is of great importance and economic significance. Recent studies reveal that caffeine can be converted into non-stimulatory theacrine in the rare tea plant Camellia assamica var. kucha (Kucha), which involves oxidation at the C8 and methylation at the N9 positions of caffeine. However, the underlying molecular mechanism remains unclear. Here, we identify the theacrine synthase CkTcS from Kucha, which possesses novel N9-methyltransferase activity using 1,3,7-trimethyluric acid but not caffeine as a substrate, confirming that C8 oxidation takes place prior to N9-methylation. The crystal structure of the CkTcS complex reveals the key residues that are required for the N9-methylation, providing insights into how caffeine N-methyltransferases in tea plants have evolved to catalyze regioselective N-methylation through fine tuning of their active sites.
    [Show full text]
  • Pharmacokinetics of Caffeine: a Systematic Analysis of Reported Data
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.12.452094; this version posted August 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing Jan Grzegorzewski 1, Florian Bartsch 1, Adrian Koller¨ 1, and Matthias Konig¨ 1;∗ 1Institute for Theoretical Biology, Humboldt-University Berlin, Invalidenstraße 110, 10115 Berlin, Germany Correspondence*: Matthias Konig¨ [email protected] ABSTRACT Caffeine is by far the most ubiquitous psychostimulant worldwide found in tea, coffee, cocoa, energy drinks, and many other beverages and food. Caffeine is almost exclusively metabolized in the liver by the cytochrome P-450 enzyme system to the main product paraxanthine and the additional products theobromine and theophylline. Besides its stimulating properties, two important applications of caffeine are metabolic phenotyping of cytochrome P450 1A2 (CYP1A2) and liver function testing. An open challenge in this context is to identify underlying causes of the large inter-individual variability in caffeine pharmacokinetics. Data is urgently needed to understand and quantify confounding factors such as lifestyle (e.g. smoking), the effects of drug-caffeine interactions (e.g. medication metabolized via CYP1A2), and the effect of disease. Here we report the first integrative and systematic analysis of data on caffeine pharmacokinetics from 148 publications and provide a comprehensive high-quality data set on the pharmacokinetics of caffeine, caffeine metabolites, and their metabolic ratios in human adults. The data set is enriched by meta-data on the characteristics of studied patient cohorts and subjects (e.g.
    [Show full text]
  • Caffeine and Chlorogenic Acid Contents Among Wild Coffea
    Food Chemistry Food Chemistry 93 (2005) 135–139 www.elsevier.com/locate/foodchem Qualitative relationship between caffeine and chlorogenic acid contents among wild Coffea species C. Campa, S. Doulbeau, S. Dussert, S. Hamon, M. Noirot * Centre IRD of Montpellier, B.P. 64501, 34394 Montpellier Cedex 5, France Received 28 June 2004; received in revised form 13 October 2004; accepted 13 October 2004 Abstract Chlorogenic acids, sensu largo (CGA), are secondary metabolites of great economic importance in coffee: their accumulation in green beans contributes to coffee drink bitterness. Previous evaluations have already focussed on wild species of coffee trees, but this assessment included six new taxa from Cameroon and Congo and involved a simplified method that generated more accurate results. Five main results were obtained: (1) Cameroon and Congo were found to be a centre of diversity, encompassing the entire range of CGA content from 0.8% to 11.9% dry matter basis (dmb); (2) three groups of coffee tree species – CGA1, CGA2 and CGA3 – were established on the basis of discontinuities; (3) means were 1.4%, 5.6% and 9.9% dmb, respectively; (4) there was a qualitative relation- ship between caffeine and ACG content distribution; (5) only a small part of the CGA is trapped by caffeine as caffeine chlorogenate. Ó 2004 Elsevier Ltd. All rights reserved. Keywords: Coffeae; Caffeine; Chlorogenic acids 1. Introduction lic acid [feruloylquinic acids (FQA)] and represent 98% of all CGAs (Clifford, 1985; Morishita, Iwahashi, & Two coffee species, C. canephora and C. arabica, are Kido, 1989). There are also some minor compounds, cultivated worldwide. However, these species only repre- such as esters of feruloyl-caffeoylquinic acids (FCQA), sent a small proportion of the worldÕs coffee genetic re- caffeoyl-feruloylquinic acids (CFQA) or p-coumaric acid sources as, in the wild, the Coffea subgenus (Coffea (p-CoQA).
    [Show full text]
  • Theacrine Attenuates Myocardial Fibrosis After Myocardial Infarction Via the SIRT3/Β-Catenin/ Pparγ Pathway in Estrogen-Deficient Mice
    European Review for Medical and Pharmacological Sciences 2019; 23: 5477-5486 Theacrine attenuates myocardial fibrosis after myocardial infarction via the SIRT3/β-catenin/ PPARγ pathway in estrogen-deficient mice L.-L. SONG1, Y. ZHANG2, X.-R. ZHANG3, Y.-N. SONG4, H.-Z. DAI5 1Department of Critical Care Medicine, Weifang Hanting District People’s Hospital, Weifang, China 2Department of Respiratory Medicine, Weifang Hanting District People’s Hospital, Weifang, China 3Department of Pharmacology, Weifang Medical University, Weifang, China 4Department of Breast and Thyroid Surgery, The Traditional Chinese Medicine Hospital of Weifang, Weifang, China 5Department of Emergency, The Affiliated Hospital of Weifang Medical University, Weifang, China Abstract. – OBJECTIVE: To investigate the myocardial apoptosis were clearly aggravated, role of theacrine in the protection of ventricular and the SIRT3 expression was decreased at 28 remodeling and chronic heart failure after myo- days after myocardial infarction. The theacrine cardial infarction in the estrogen-deficient mice. could improve the cardiac function after the MATERIALS AND METHODS: Female myocardial infarction in estrogen-deficient mice C57BL/6 mice aged 8 weeks old were selected and relieve both myocardial fibrosis and myo- and then subjected to bilateral oophorectomy. cardial apoptosis during chronic remodeling af- At 7 days after surgery, the models of the myo- ter myocardial infarction in estrogen-deficient cardial infarction were established by ligating mice. After the intervention with theacrine, the the anterior descending coronary artery. On the estrogen-deficient mice with myocardial infarc- first day after myocardial infarction, Theacrine tion had up-regulated SIRT3 and PPARγ levels (20 mg/kg) was administered via gavage for con- and a reduced β-catenin level in the heart.
    [Show full text]
  • Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times
    Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times Each volume in this series provides academia, health sciences, and the herbal medicines industry with in-depth coverage of the herbal remedies for infectious diseases, certain medical conditions, or the plant medicines of a particular country. Series Editor: Dr. Roland Hardman Volume 1 Shengmai San, edited by Kam-Ming Ko Volume 2 Rasayana: Ayurvedic Herbs for Rejuvenation and Longevity, by H.S. Puri Volume 3 Sho-Saiko-To: (Xiao-Chai-Hu-Tang) Scientific Evaluation and Clinical Applications, by Yukio Ogihara and Masaki Aburada Volume 4 Traditional Medicinal Plants and Malaria, edited by Merlin Willcox, Gerard Bodeker, and Philippe Rasoanaivo Volume 5 Juzen-taiho-to (Shi-Quan-Da-Bu-Tang): Scientific Evaluation and Clinical Applications, edited by Haruki Yamada and Ikuo Saiki Volume 6 Traditional Medicines for Modern Times: Antidiabetic Plants, edited by Amala Soumyanath Volume 7 Bupleurum Species: Scientific Evaluation and Clinical Applications, edited by Sheng-Li Pan Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Bruno Burlando, Luisella Verotta, Laura Cornara, and Elisa Bottini-Massa Cover art design by Carlo Del Vecchio. CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-1-4398-1214-3 (Ebook-PDF) This book contains information obtained from authentic and highly regarded sources.
    [Show full text]
  • The Two Tortoitumia Ultimate Tatli Himin
    THETWO TORTOITUMIAUS 20180104248A1ULTIMATE TATLI HIMIN ( 19) United States ( 12) Patent Application Publication ( 10 ) Pub . No. : US 2018 /0104248 A1 Lopez et al. (43 ) Pub . Date : Apr . 19 , 2018 ( 54 ) THEACRINE -BASED SUPPLEMENT AND Publication Classification METHOD OF USE THEREOF IN A (51 ) Int. Cl. SYNERGISTIC COMBINATION WITH A61K 31/ 522 ( 2006 . 01 ) CAFFEINE C07D 487/ 04 (2006 . 01) (52 ) U . S . CI. @( 71 ) Applicant : Ortho - Nutra, LLC , Morganville , NJ CPC .. A61K 31/ 522 ( 2013 .01 ) ; C07D 487 /04 (US ) ( 2013. 01 ) @(72 ) Inventors : Hector L Lopez , Cream Ridge , NJ (US ) ; Shawn Wells , Lewisville , TX (US ) ; Tim N . Ziegenfuss , Chardon , OH (57 ) ABSTRACT (US ) A human dietary supplement comprises theacrine and @( 73 ) Assignee : Ortho -Nutra , LLC , Morganville , NJ optionally other compounds that modulate the effects of theacrine . Uses for the theacrine - containing supplement (US ) include improvement of at least one ofmood , energy, focus, concentration or sexual desire or a reduction of at least one (21 ) Appl. No. : 15 /600 , 371 of anxiety or fatigue. A synergistic composition comprises ( 22 ) Filed : May 19 , 2017 co -administration of theacrine and caffeine , wherein the co - administered caffeine reduces theacrine oral clearance Related U . S . Application Data (CL / F ) and oral volume of distribution (Vd / F ) . In addition , the co - administered caffeine increases area under the plasma (63 ) Continuation - in -part of application No. 14 / 539, 726 , concentration time curve ( AUC ) of theacrine , and increases filed on Nov. 12 , 2014 . theacrine maximum plasma concentration ( Cmax ) in com (60 ) Provisional application No .61 / 903 ,362 , filed on Nov . parison with the corresponding pharmacokinetic parameters 12 , 2013 .
    [Show full text]
  • Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
    pharmaceutics Review Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction Maria D. Auxtero 1, Susana Chalante 1,Mário R. Abade 1 , Rui Jorge 1,2,3 and Ana I. Fernandes 1,* 1 CiiEM, Interdisciplinary Research Centre Egas Moniz, Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal; [email protected] (M.D.A.); [email protected] (S.C.); [email protected] (M.R.A.); [email protected] (R.J.) 2 Polytechnic Institute of Santarém, School of Agriculture, Quinta do Galinheiro, 2001-904 Santarém, Portugal 3 CIEQV, Life Quality Research Centre, IPSantarém/IPLeiria, Avenida Dr. Mário Soares, 110, 2040-413 Rio Maior, Portugal * Correspondence: [email protected]; Tel.: +35-12-1294-6823 Abstract: Late-life mild cognitive impairment and dementia represent a significant burden on health- care systems and a unique challenge to medicine due to the currently limited treatment options. Plant phytochemicals have been considered in alternative, or complementary, prevention and treat- ment strategies. Herbals are consumed as such, or as food supplements, whose consumption has recently increased. However, these products are not exempt from adverse effects and pharmaco- logical interactions, presenting a special risk in aged, polymedicated individuals. Understanding pharmacokinetic and pharmacodynamic interactions is warranted to avoid undesirable adverse drug reactions, which may result in unwanted side-effects or therapeutic failure. The present study reviews the potential interactions between selected bioactive compounds (170) used by seniors for cognitive enhancement and representative drugs of 10 pharmacotherapeutic classes commonly prescribed to the middle-aged adults, often multimorbid and polymedicated, to anticipate and prevent risks arising from their co-administration.
    [Show full text]
  • The Effects of Teacrine and Caffeine on Endurance and Cognitive
    THE EFFECTS OF TEACRINE AND CAFFEINE ON ENDURANCE AND COGNITIVE PERFORMANCE DURING A SIMULATED MATCH IN HIGH-LEVEL SOCCER PLAYERS By MARISSA L. BELLO A thesis submitted to the School of Graduate Studies Rutgers, The State University of New Jersey In partial fulfillment of the requirements For the degree of Master of Science Graduate Program in Kinesiology and Applied Physiology Written under the direction of Shawn M. Arent And approved by ___________________ ___________________ ___________________ New Brunswick, NJ [January 2019] ABSTRACT OF THE THESIS The Effects of Teacrine and Caffeine on Endurance and Cognitive Performance During a Simulated Match in High-Level Soccer Players by MARISSA L. BELLO Thesis Director Shawn M. Arent Theacrine (1,3,7,9-tetramethyluric-acid) is a pure alkaloid with a similar structure to caffeine and acts comparably as an adenosine receptor antagonist. Early studies have shown non-habituating effects, including increases in energy, focus, and concentration in Teacrine®, the compound containing pure theacrine. PURPOSE: to determine and compare the effects of Teacrine® and caffeine on cognitive performance and time-to-exhaustion during a simulated soccer game in high- level male and female athletes. METHODS: Elite male and female soccer players (N=24; MAge=20.96±2.05y, MMaleVO2max=55.31±3.39mL/O2/kg, MFemaleVO2max=50.97±3.90mL/O2/kg) completed a simulated 90-min soccer match protocol on a treadmill, with cognitive testing including simple reaction time (SRT); choice-RT during a go/no-go task (CRT); and complex-RT during a dual task of go/no go (COGRT) with distraction questions at halftime, and end-of-game.
    [Show full text]
  • LC–MS/MS) Method for Characterizing Caffeine, Methylliberine, and Theacrine Pharmacokinetics in Humans Yan-Hong Wanga, Goutam Mondala, Matthew Butawanb, Richard J
    Journal of Chromatography B 1155 (2020) 122278 Contents lists available at ScienceDirect Journal of Chromatography B journal homepage: www.elsevier.com/locate/jchromb Development of a liquid chromatography-tandem mass spectrometry T (LC–MS/MS) method for characterizing caffeine, methylliberine, and theacrine pharmacokinetics in humans Yan-Hong Wanga, Goutam Mondala, Matthew Butawanb, Richard J. Bloomerb, ⁎ Charles R. Yatesa,c, a The National Center for Natural Products Research, University of Mississippi, Oxford, MS, USA b Cardiorespiratory/Metabolic Laboratory, School of Health Studies, University of Memphis, Memphis, TN, USA c NPI, LLC, Oxford, MS, USA ARTICLE INFO ABSTRACT Keywords: Coffea liberica possesses stimulant properties without accumulating the methylxanthine caffeine. The basis for LC-MS/MS this peculiar observation is that methylurates (e.g., theacrine and methylliberine) have replaced caffeine. The Caffeine stimulant properties of methylurates, alone and in combination with caffeine, have recently been investigated. Methylliberine However, human pharmacokinetics and LC-MS/MS methods for simultaneous measurement of methylxanthines Theacrine and methylurates are lacking. To address this deficiency, we conducted a pharmacokinetic study in which Human pharmacokinetics subjects (n = 12) were orally administered caffeine (150 mg), methylliberine (Dynamine™, 100 mg), and theacrine (TeaCrine®, 50 mg) followed by blood sampling over 24 h. Liquid-liquid extraction of plasma samples containing purine alkaloids and internal standard (13C-Caffeine) were analyzed using a C18 reversed-phase column and gradient elution (acetonitrile and water, both containing 0.1% formic acid). A Waters Xevo TQ-S tandem mass spectrometer (positive mode) was used to detect caffeine, methylliberine, theacrine, and IS tran- sitions of m/z 195.11 → 138.01, 225.12 → 168.02, 225.12 → 167.95, and 198.1 → 140.07, respectively.
    [Show full text]
  • Assessment of Pharmacokinetic Interaction Potential Between Caffeine and Methylliberine
    medRxiv preprint doi: https://doi.org/10.1101/2021.01.05.21249234; this version posted January 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Assessment of Pharmacokinetic Interaction Potential Between Caffeine and Methylliberine Running Title: Pharmacokinetics of Dynamine Authors: Goutam Mondal, PhD1 Yan-Hong Wang, PhD1 Matthew Butawan, BS2 Richard J. Bloomer, PhD2 Charles R. Yates, PharmD, PhD1,3 Affiliations: 1The National Center for Natural Products Research, University of Mississippi, Oxford, MS, USA 2Cardiorespiratory/Metabolic Laboratory, School of Health Studies, University of Memphis, Memphis, TN, USA 3NPI, LLC, Oxford, MS Correspondence should be sent to: Charles R. Yates Thad Cochran Research Center West National Center for Natural Products Research Oxford, MS, 38677-1848 Phone: (662) 915-6994 Email: [email protected] Key Words: caffeine, methylliberine, theacrine, and pharmacokinetics NOTE: This preprint reports new research that has not been certified1 by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2021.01.05.21249234; this version posted January 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Methylliberine and theacrine are methylurates found in the leaves of various Coffea species and Camellia assamica var. kucha, respectively. We previously demonstrated that the methylxanthine caffeine increased theacrine’s oral bioavailability in humans.
    [Show full text]
  • The Two Tonditionwinkturtin
    THETWO TONDITIONWINKTURTINUS 20170232103A1 ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2017/ 0232103 A1 Soane et al. (43 ) Pub. Date : Aug . 17, 2017 ( 54 ) EXCIPIENT COMPOUNDS FOR plication No . 62/ 245 , 513 , filed on Oct . 23, 2015 , BIOPOLYMER FORMULATIONS provisional application No . 62/ 245 ,513 , filed on Oct . (71 ) Applicant : ReForm Biologics , LLC , Cambridge , 23 , 2015 . MA (US ) Publication Classification (51 ) Int. Cl. (72 ) Inventors : David S . Soane , Palm Beach , FL (US ) ; A61K 39 /395 ( 2006 . 01 ) Philip Wuthrich , Belmont, MA (US ) ; A61K 47 / 12 (2006 . 01 ) Rosa Casado Portilla , Peabody , MA CO7K 16 /22 ( 2006 .01 ) (US ) ; Robert P . Mahoney , Newbury , A61K 47 /22 (2006 . 01 ) MA (US ) ; Mark Moody , Concord , MA CO7K 16 / 24 ( 2006 .01 ) (US ) ; Daniel G . Greene , Belmont , MA COZK 16 / 32 ( 2006 .01 ) (US ) (52 ) U . S . CI. CPC . .. A61K 39 / 39591 (2013 . 01 ) ; CO7K 16 / 241 ( 21) Appl . No. : 15 /331 , 197 ( 2013 . 01 ) ; CO7K 16 / 32 (2013 .01 ) ; CO7K 16 / 22 ( 2013 . 01 ) ; A61K 47/ 48215 ( 2013 .01 ) ; A61K (22 ) Filed : Oct . 21 , 2016 47 / 22 ( 2013 . 01 ) ; A61K 47 / 12 ( 2013 . 01) ; COZK 2317 /21 ( 2013 .01 ) ; CO7K 2317 /24 (2013 .01 ) Related U . S . Application Data ( 57 ) ABSTRACT (63 ) Continuation - in -part of application No . 14 / 966 ,549 , The invention encompasses formulations and methods for filed on Dec. 11 , 2015 , now Pat . No . 9 ,605 , 051 , which the production thereof that permit the delivery of concen is a continuation of application No . 14 /744 , 847 , filed trated protein solutions. The inventive methods can yield a on Jun .
    [Show full text]